Company Filing History:
4 out of 2,198 Years Active: 1997-2000
Title: Innovator Spotlight: Kerry Joseph Gombatz from West Chester, PA
Introduction
Kerry Joseph Gombatz is an accomplished inventor located in West Chester, Pennsylvania. He has made significant contributions to the field of organic chemistry, particularly through his innovative work on endothelin receptor antagonists. With a total of three patents to his name, Gombatz exemplifies the spirit of innovation in the pharmaceutical industry.
Latest Patents
Gombatz’s most recent inventions primarily focus on the stereoselective synthesis of endothelin receptor antagonists. His latest patent details a synthetic route for preparing chiral intermediates that are crucial for these receptor antagonists, specifically in the development of pharmaceutical compounds that target endothelin pathways. This work is poised to contribute to advancements in treatments for various cardiovascular diseases.
Career Highlights
Throughout his career, Gombatz has been associated with the prestigious SmithKline Beecham Corporation, a leading player in the pharmaceutical sector. His tenure there has allowed him to collaborate with other talented professionals and contribute to significant advancements in drug development. His dedication to research and innovation has made him a valuable asset to his company.
Collaborations
Kerry Gombatz has worked alongside esteemed colleagues such as Robert John Mills and Conrad John Kowalski. This collaborative environment has fostered the sharing of ideas and expertise, allowing them to push the boundaries of research and innovation within their projects. Their combined efforts have led to breakthroughs that enhance therapeutic options available for patients.
Conclusion
In summary, Kerry Joseph Gombatz stands out as a notable inventor in the realm of pharmaceutical innovations. His body of work, particularly in the synthesis of endothelin receptor antagonists, showcases not only his inventiveness but also his commitment to improving health outcomes through scientific research. With a solid foundation in collaboration and innovation, Gombatz is well-positioned to continue making impactful contributions in his field.